Do you have the same question? Follow this Question
Mar 06, 2026 - 11:22 AM
We’ve provided several answers to questions related to Lagevrio (Molnupiravir) , see some other helpful Q&A related to this product.
Question: What brand is this medication sold under?
Answer: It is sold under the brand name Lagevrio. Knowing the brand name helps avoid confusion with other medications.
Question: What is the KEGG code for this medication?
Answer: The KEGG code is D12413. KEGG (Kyoto Encyclopedia of Genes and Genomes) is a resource for understanding high-level functions of biological systems, valuable for research and medical professionals.
Question: What are the licensing authorities for this medication?
Answer: This medication is authorized under the US FDA Emergency Use Authorization (EUA) and the UK MHRA (Medicines and Healthcare products Regulatory Agency). Knowing the licensing authorities can provide assurance about regulatory oversight and safety.
Question: What is the elimination half-life of the active metabolite?
Answer: The elimination half-life is approximately 3.3 hours. The half-life indicates how long the active substance remains in the body, which affects dosing intervals and duration of action.
Question: How is this medication taken?
Answer: The medication is taken orally, meaning it is swallowed by mouth. Oral administration is convenient and familiar for most patients.
